
Alcohol-related liver disease has doubled in the last 20 years; this nasal spray delivers Alzheimer’s drug to brain; Trump admin to destroy $9.7M in contraceptives meant for global aid – Morning Medical Update
Key Takeaways
- Alcohol-related liver disease has surged in the U.S., driven by high-risk groups like women, older adults, and those with metabolic syndrome, despite stable drinking rates.
- Intranasal insulin delivery to memory-related brain regions shows promise for Alzheimer's treatment, with varying absorption in patients with mild cognitive impairment.
The top news stories in medicine today.
Cases of alcohol-related liver disease in the U.S. have more than doubled over the past 20 years, according to a Keck Medicine of USC study in
A Wake Forest study has validated that intranasal insulin reaches memory-related brain regions, offering a promising new delivery method for Alzheimer’s treatments. Published in
The Trump administration will
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.



















